UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000010077
Receipt No. R000011805
Official scientific title of the study The effect of histamine on acethylcholine-mediated sweating
Date of disclosure of the study information 2013/02/19
Last modified on 2018/12/31 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The effect of histamine on acethylcholine-mediated sweating
Title of the study (Brief title) The effect of histamine on sweating
Region
Japan

Condition
Condition Healthy volunteers who were enrolled to this study after they signed an informed consent form and provided written and oral information to the study physicians.
Classification by specialty
Dermatology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Evaluating the effect of histamine on sweating
Basic objectives2 Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes 1) axon-reflex mediated sweating volume
2) latency time
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 with or without histamine
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Subjects with signed an informed consent form and provided written and oral information to the study physicians.
Key exclusion criteria - The part-time-service personnel, a fixed-term employment person
- Whose consent was not obtained
-Subjects with glaucoma, cholinergic urticaria, asthma, prostatic hypertrophy, a pregnant woman, the woman under breast-feeding
-Subjects with dermatoses in a test lesion
Target sample size 20

Research contact person
Name of lead principal investigator Hiroyuki Murota
Organization Osaka university, School of medicine
Division name Dermatology
Address 2-2, Yamadaoka, Suita, Osaka
TEL 0668795111
Email h-murota@derma.med.osaka-u.ac.jp

Public contact
Name of contact person 0668795111
Organization Osaka univeristy
Division name Dermatology
Address 2-2, yamadaoka, suita
TEL 0668795111
Homepage URL
Email h-murota@derma.med.osaka-u.ac.jp

Sponsor
Institute Dept. of dermatology, Osaka university
Institute
Department

Funding Source
Organization Dept. of dermatology, Osaka university
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 02 Month 19 Day

Progress
Recruitment status Completed
Date of protocol fixation
2012 Year 08 Month 31 Day
Anticipated trial start date
2012 Year 10 Month 11 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 02 Month 19 Day
Last modified on
2018 Year 12 Month 31 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000011805